Effective tumor treatment was associated with enhanced infiltration, and the expansion and persistence of anti-VEGFR2 CAR plus IL-12-engineered T-cells compared to anti-VEGFR-2 CAR T-cells alone [56]. This evidence concerns the gene KDR and neoplasm.